Holen Sie sich die Stockscreener-App
6.47
0.31%
-0.02
Schlusskurs vom Vortag:
$6.49
Offen:
$6.49
24-Stunden-Volumen:
8,227
Relative Volume:
0.76
Marktkapitalisierung:
$464.94M
Einnahmen:
$510.62M
Nettoeinkommen (Verlust:
$110.37M
KGV:
6.883
EPS:
0.94
Netto-Cashflow:
$423.23M
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$5.73
$8.75
Sinovac Biotech, Ltd Stock (SVA) Company Profile
Firmenname
Sinovac Biotech, Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare SVA vs
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SVA
Sinovac Biotech, Ltd
|
6.47 | 464.94M | 510.62M | 110.37M | 423.23M | 0.94 |
Sinovac Biotech, Ltd Aktie (SVA) Neueste Nachrichten
Licensable picture: A technician puts a bottle of H1N1 flu virus into a transfer cabinet during preparations to produce vaccines for the flu virus at a lab in Wuhan - reutersconnect.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its OfficersSVA - TMX Newsfile
Licensable picture: Technician works in inoculation area of Sinovac Biotech Ltd. during production of a vaccine for the H1N1 flu virus in Beijing - reutersconnect.com
Sinovac Biotech Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
1Globe Capital Deadline Alert - TMX Newsfile
Sinovac Biotech, Ltd. Revenue Breakdown – NASDAQ:SVA - TradingView
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend - Via TT
Price to book forward of Sinovac Biotech, Ltd. – NASDAQ:SVA - TradingView
Sinovac Biotech LtdADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Sinovac Biotech LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Enterprise value to EBIT forward of Sinovac Biotech, Ltd. – NASDAQ:SVA - TradingView
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements - Via TT
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements - STT Info
Sinovac faces delisting after missing 2025 annual report filing - Investing.com
Chancery Sends Sinovac Biotech Suit To Antigua And Barbuda - Law360
Sinovac Controlling Shareholders Escape Investor Disclosure Suit - Bloomberg Law News
Sinovac Wins Nasdaq Reprieve as Governance Fight Drags On - Caixin Global
Sinovac's inactivated hepatitis A vaccine wins contract in Oman - China Daily
Chinese firm Sinovac to supply vaccine to Chile ahead of flu season - scmp.com
Sinovac receives second Nasdaq non-compliance notice - Investing.com
Antigua court sets Sinovac board until 2026 trial over disputed meeting - Investing.com
Sinovac faces Nasdaq delisting over delayed annual report filing - Investing.com
Sinovac expands flu vaccine age range to 6 months and older - China Daily
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment - Yahoo Finance
Sinovac shareholders push for payment of declared $19 dividend - Investing.com
BreakingviewsCOMMENTARY: Biotech nears cure for Chinese corporate epidemic - Reuters
Finanzdaten der Sinovac Biotech, Ltd-Aktie (SVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):